Patents by Inventor Michael Serby

Michael Serby has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060173050
    Abstract: The present invention relates to compounds that are inhibitors of c-jun N-terminal kinase 1, 2, or 3 (JNK1, JNK2, or JNK3), compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the activation of JNK1, JNK2 and JNK3.
    Type: Application
    Filed: January 23, 2006
    Publication date: August 3, 2006
    Inventors: Gang Liu, Hing Sham, Bruce Szczepankiewicz, Zhili Xin, Hongyu Zhao, Michael Serby, Bo Liu, Mei Liu
  • Publication number: 20060089398
    Abstract: The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by ghrelin including anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus.
    Type: Application
    Filed: March 10, 2004
    Publication date: April 27, 2006
    Inventors: Gang Liu, Hongyu Zhao, Michael Serby, Bo Liu, Zhili Xin, Lissa Nelson, Bruce Szczepankiewicz, Hing Sham
  • Publication number: 20050171131
    Abstract: The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the action of ghrelin receptor, including Prader-Willi syndrome, eating disorder, weight gain, weight-loss maintainance following diet and exercise, obesity, and disorders associated with obesity such as noninsulin dependent diabetes mellitus.
    Type: Application
    Filed: September 23, 2004
    Publication date: August 4, 2005
    Inventors: Christi Kosogof, Bo Liu, Gang Liu, Mei Liu, Lissa Nelson, Michael Serby, Hing Sham, Bruce Szczepankiewicz, Zhili Xin, Hongyu Zhao
  • Publication number: 20050171132
    Abstract: The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by the action of ghrelin receptor, including Prader-Willi syndrome, eating disorder, weight gain, weight-loss maintainance following diet and exercise, obesity and disorders associated with obesity such as non-insulin dependent diabetes mellitus.
    Type: Application
    Filed: September 23, 2004
    Publication date: August 4, 2005
    Inventors: Zhili Xin, Bo Liu, Gang Liu, Mei Liu, Michael Serby, Hongyu Zhao
  • Publication number: 20050070712
    Abstract: The present invention is related to compounds of formula (I), or a therapeutically suitable salt or prodrug thereof, the preparation of the compounds, compositions containing the compounds and the use of the compounds in the prevention or treatment of disorders regulated by ghrelin including anorexia, cancer cachexia, eating disorders, age-related decline in body composition, weight gain, obesity, and diabetes mellitus.
    Type: Application
    Filed: September 26, 2003
    Publication date: March 31, 2005
    Inventors: Christi Kosogof, Bo Liu, Gang Liu, Mei Liu, Lissa Nelson, Michael Serby, Hing Sham, Bruce Szczepankiewicz, Zhili Xin, Hongyu Zhao